News

Food and Drug Administration Commissioner Marty Makary said in a recent interview he has no plans to change policies ...
Commissioner Marty Makary said in an interview with Politico’s Dasha Burns that the FDA will “look at the data” surrounding ...
Mike Pence's think tank is asking the Food and Drug Administration to turn over documents related to the dangers of the ...
FDA Commissioner Dr. Marty Makary joins Morning Joe to address the agency’s controversial decision to keep Juul e-cigarettes ...
The FDA says access to Mifepristone will stay the same — despite safety reviews and pressure from some Republican lawmakers.
More than 50 biotech leaders and investors are urging the FDA to disregard a methodologically flawed report on mifepristone.
F ood and Drug Administration Commissioner Marty Makary said he has “no preconceived plans” to change the policies on mifepristone, an abortion pill that ends pregnancy before 10 weeks, in an ...
Pro-life medical groups are urging Health and Human Services Secretary Robert Kennedy Jr. to reexamine the FDA’s broad ...
Missouri Attorney General Andrew Bailey is suing the national Planned Parenthood organization over its claims regarding the ...
West Virginia can block access to the abortion-inducing drug mifepristone, a federal appeals court said Tuesday in a landmark ...
Mifepristone, also sold under the brand name Mifeprex, is approved by the FDA to end a pregnancy up to 10 weeks. The single tablet works by blocking the hormone progesterone and is typically ...
President Trump said he was likely to impose tariffs on pharmaceuticals as soon as the end of the month, starting with a "low ...